Publication:
Long-Term Outcome of Acute Coronary Syndromes in Patients on Chronic Oral Anticoagulants: Data from the EPICOR Study.

Thumbnail Image
Files
Long-TermOutcomeAcute_2020.pdf (675.4 KB)
Identifiers
URI: http://hdl.handle.net/20.500.12105/11283
ISSN: 1570-1611
DOI: 10.2174/1570161117666181227122355
Publication date
2020-01
Authors
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Bentham Science Publishers
Metrics
Google Scholar
Export
MarcXML METS
Research Projects
Organizational Units
Journal Issue
Abstract
To analyze characteristics, management and outcomes of patients with acute coronary syndromes (ACS) receiving chronic oral anticoagulant (OAC) therapy enrolled in the EPICOR (long-tErm follow-uP of antithrombotic management patterns In acute CORonary syndrome patients) prospective, international, observational study of antithrombotic management patterns in ACS survivors (NCT01171404). This post-hoc analysis evaluated the association between OAC use at baseline (OACb) and time from hospital admission to percutaneous coronary intervention (PCI) (tHA-PCI), pre-PCI thrombolysis in myocardial infarction (TIMI) 3 flow, stent type, length of hospitalization, and clinical endpoints; death, non-fatal MI, and non-fatal stroke, a composite of these ± bleeding, over 2 years' followup. Of 10,568 ACS patients, 345 (3.3%) were on OACb (non-ST-segment elevation ACS [NSTEACS], n=268; ST-segment elevation MI [STEMI], n=77). OACb patients were older with more comorbidities. In NSTE-ACS OACb patients, tHA-PCI was longer (median 57.4 vs. 27.8 h; p=.008), and TIMI 3 flow rarer (26.0 vs. 33.5%; p=0.035). OACb patients had longer mean hospital stay (NSTEACS: 8.9 vs. 7.6 days; p<0.001; STEMI: 9.5 vs. 7.8 days; p=0.015), and higher rates of the composite endpoint (NSTE-ACS: 16.8 vs. 8.8%; p<0.0001; STEMI: 23.4 vs. 5.9%; p<0.0001). Bleeding events were more common with OACb (NSTE-ACS: 6.0 vs. 3.3%; p=0.01; STEMI: 6.5 vs. 2.8%; p=0.04). At 2-years, OACb use was associated with an increased risk of cardiovascular and bleeding events in STEMI and NSTE-ACS. NSTE-ACS patients on OACb experienced prolonged time to intervention, lower rates of TIMI 3 flow and longer hospitalization.
Description
Keywords
MeSH Terms
Percutaneous Coronary Intervention Acute Coronary Syndrome Administration, Oral Aged
DeCS Terms
Bibliographic citation
Curr Vasc Pharmacol. 2020; 18(1):92-99
Collections
Grupos de investigación
Publisher version
https://doi.org/10.2174/1570161117666181227122355
Document type
journal article